Annual dialysis data report 2017, JS']JSDT Renal Data Registry

被引:100
作者
Nitta, Kosaku [1 ]
Masakane, Ikuto [2 ]
Hanafusa, Norio [1 ]
Taniguchi, Masatomo [1 ]
Hasegawa, Takeshi [1 ]
Nakai, Shigeru [1 ]
Goto, Shunsuke [1 ]
Wada, Atsushi [1 ]
Hamano, Takayuki [1 ]
Hoshino, Junichi [1 ]
Joki, Nobuhiko [1 ]
Abe, Masaki [1 ]
Yamamoto, Keichi [1 ]
Nakamoto, Hidetomo [1 ]
机构
[1] Japanese Soc Dialysis Therapy, Japanese Soc Dialysis Therapy Renal Data Registry, Tokyo, Japan
[2] Yabuki Hosp, Dept Nephrol, 4-5-5 Shimakita, Yamagata, Yamagata 99000885, Japan
关键词
MAINTENANCE HEMODIALYSIS; JAPANESE SOCIETY; MORTALITY;
D O I
10.1186/s41100-019-0248-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was conducted for 4413 dialysis facilities at the end of 2017; among which 4360 facilities (98.8%) responded to the facility questionnaire, and 4188 (94.9%) responded to the patient questionnaire. The response rate of the 2017 survey was comparable with the past, even though it was the third year after the new anonymization method. The number of chronic dialysis patients in Japan continues to increase every year; it has reached 334,505 at the end of 2017. The mean age was 68.43 years. The prevalence rate was 2640 patients per million population. Diabetic nephropathy was the most common primary disease among the prevalent dialysis patients (39.0%), followed by chronic glomerulonephritis (27.8%) and nephrosclerosis (10.3%). The rate of diabetic nephropathy and nephrosclerosis has been increasing year by year, whereas that of chronic glomerulonephritis was declining. The number of incident dialysis patients during 2017 was 40,959; it has remained stable since 2008. The average age was 69.68 years and diabetic nephropathy (42.5%) was the most common cause in the incident dialysis patients. These patients caused by diabetes did not change in number for recent several years. Further, 32,532 patients died in 2017; the crude mortality rate was 9.8%. The patients treated by hemodiafiltration (HDF) have been increasing rapidly from the revision of medical reimbursement for HDF therapy in 2012. It has attained 95,140 patients at the end of 2017, which were 18,304 greater than that in 2016. The number of peritoneal dialysis (PD) patients was 9090 in 2017, which had been slightly decreasing since 2014. Further, 19.4% of PD patients treated in the combination of hemodialysis (HD) or HDF therapy (hybrid therapy). And 984 patients were treated by home HD therapy at the end of 2017; it increased by 49 from 2016.
引用
收藏
页数:44
相关论文
共 14 条
  • [1] Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry
    Abe, Masanori
    Hamano, Takayuki
    Wada, Atsushi
    Nakai, Shigeru
    Masakane, Ikuto
    [J]. PLOS ONE, 2017, 12 (09):
  • [2] High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry
    Abe, Masanori
    Hamano, Takayuki
    Wada, Atsushi
    Nakai, Shigeru
    Masakane, Ikuto
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2017, 46 (01) : 82 - 92
  • [3] [Anonymous], 2017, INT COMP 2017 USRDS
  • [4] Dialysis Fluid Endotoxin Level and Mortality in Maintenance Hemodialysis: A Nationwide Cohort Study
    Hasegawa, Takeshi
    Nakai, Shigeru
    Masakane, Ikuto
    Watanabe, Yuzo
    Iseki, Kunitoshi
    Tsubakihara, Yoshiharu
    Akizawa, Tadao
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (06) : 899 - 904
  • [5] Standard on Microbiological Management of Fluids for Hemodialysis and Related Therapies by the Japanese Society for Dialysis Therapy 2008
    Kawanishi, Hideki
    Akiba, Takashi
    Masakane, Ikuto
    Tomo, Tadashi
    Mineshima, Michio
    Kawasaki, Tadayuki
    Hirakata, Hideki
    Akizawa, Tadao
    [J]. THERAPEUTIC APHERESIS AND DIALYSIS, 2009, 13 (02) : 161 - 166
  • [6] Predilution online hemodiafiltration is associated with improved survival compared with hemodialysis
    Kikuchi, Kan
    Hamano, Takayuki
    Wada, Atsushi
    Nakai, Shigeru
    Masakane, Ikuto
    [J]. KIDNEY INTERNATIONAL, 2019, 95 (04) : 929 - 938
  • [7] ISPD PERITONITIS RECOMMENDATIONS: 2016 UPDATE ON PREVENTION AND TREATMENT
    Li, Philip Kam-Tao
    Szeto, Cheuk Chun
    Piraino, Beth
    de Arteaga, Javier
    Fan, Stanley
    Figueiredo, Ana E.
    Fish, Douglas N.
    Goffin, Eric
    Kim, Yong-Lim
    Salzer, William
    Struijk, Dirk G.
    Teitelbaum, Isaac
    Johnson, David W.
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2016, 36 (05): : 481 - 508
  • [8] Masakane I., 2016, J Jpn Soc Dial Ther, V49, P211, DOI [10.4009/jsdt.49.211, DOI 10.4009/JSDT.49.211]
  • [9] Mineshima M., 2018, Ren Replace Therapy, V4, P15, DOI [10.1186/s41100-018-0155-x, DOI 10.1186/S41100-018-0155-X]
  • [10] Nakai S., 2010, J Jpn Soc Dial Ther, V43, P119, DOI [10.4009/jsdt.43.119, DOI 10.4009/JSDT.43.119]